InHypo-DM Publications & Disseminations

• Ratzki‐Leewing A, Black JE, Kahkoska AR, Ryan BL, Zou G, Klar N, Timcevska K, Harris SB. Severe (level 3) hypoglycaemia occurrence in a real‐world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States). Diabetes, Obesity and Metabolism. 2023 Sep 13. https://doi.org/10.1111/dom.15268

• Rebicki CVM, Ryan BL, Ratzki-Leewing A, Tremblay PF, Harris SB. Family Physician Clinical Inertia in Managing Hypoglycemia. Prim Care Diabetes. 2022 Feb 24:S1751-9918(22)00034-1. doi: 10.1016/j.pcd.2022.02.005. Epub ahead of print. PMID: 35221245.

• Natalie H. Au, Alexandria Ratzki-Leewing, Guangyong Zou, Bridget L. Ryan, Susan Webster-Bogaert, Sonja M. Reichert, Judith B .Brown, Stewart B. Harris. Real-world incidence and risk factors for daytime and nocturnal non-severe hypoglycemia in adults with type 2 diabetes mellitus on insulin and/or secretagogues (InHypo-DM Study, Canada). Canadian Journal of Diabetes. In-press, available online https://doi.org/10.1016/j.jcjd.2021.09.004

• Brown JB, Reichert SM, Valliere Y, McLachlan C, Webster-Bogaert S, Ratzki-Leewing A, Ryan BL, Harris S. Healthcare Providers’ Emotional Responses to Their Patients’ Hypoglycemic Events: Qualitative findings from the InHypo-DM Study, Canada. Diabetes Spectrum, May 2021 https://doi.org/10.2337/ds20-0061

• Brown JB, Valliere Y, McLachlan C, Reichert SM, Webster-Bogaert S, Ratzki-Leewing A, Ryan BL, Harris SB. Beyond the Sick Role: The Many Roles of Adults With Type 1 and Type 2 Diabetes in the Management of Hypoglycemia-The InHypo-DM Study, Canada. Can J Diabetes. 2020 Oct;44(7):657-662. doi: 10.1016/j.jcjd.2020.03.011. Epub 2020 Apr 9. PMID: 32565069

• Brown JB, Reichert SM, Valliere Y, Webster-Bogaert S, Ratzki-Leewing A, Ryan BL, Harris SB. Living With Hypoglycemia: An Exploration of Patients' Emotions: Qualitative Findings From the InHypo-DM Study, Canada. Diabetes Spectr. 2019 Aug;32(3):270-276. doi: 10.2337/ds18-0074. PMID: 31462884

• Frier BM, Ratzki-Leewing A, Harris SB. Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus. Diabetes Obes Metab. 2019 Jul;21(7):1529-1542. doi: 10.1111/dom.13732. Epub 2019 Apr 29. PMID: 30924567

• Ratzki-Leewing A, Harris SB, Mequanint S, Reichert SM, Belle Brown J, Black JE, Ryan BL. Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada. BMJ Open Diabetes Res Care. 2018 Apr 24;6(1):e000503. doi: 10.1136/bmjdrc-2017-000503. PMID: 29713480

• Brown JB, Reichert SM, Valliere Y, Webster-Bogaert S, Ratzki-Leewing A, Harris SB. A qualitative enquiry of hypoglycemia and the social determinants of health: The InHypo-DM study, Canada. Fam Syst Health. 2018 Dec;36(4):471-481. doi: 10.1037/fsh0000355. Epub 2018 Jul 12. PMID: 29999342

•  

Ratzki-Leewing A, Harris SB, Au NH, Webster-Bogaert S, Brown JB, Reichert SM, Ryan BL. Age- And Sex-specific Hypoglycemia Incidence in Type 2 Diabetes (InHypo-DM Study). Canadian Journal of Diabetes. Oct. 01, 2020; 44(7):S29, 69-P.

Reichert SM, Brown JB, Valliere Y, McLachlan C, Webster-Bogaert S, Ratzki-Leewing A, Ryan BL, Au NH, Harris SB. 385-P: Health-Care Providers’ Emotional Responses to Their Patients’ Hypoglycemic Events: The InHypo-DM Study. Diabetes 2020 Jun; 69(Supplement 1): -. https://doi.org/10.2337/db20-385-P

Ratzki-Leewing A, Au NH, Ryan BL, Webster-Bogaert S, Reichert SM, Brown JB, Harris S. Real-World Risk Indicators of Severe Hypoglycemia in Type 1 Diabetes (InHypo-DM Study) EASD 2019

Au NH, Ratzki-Leewing A, Ryan BL, Webster-Bogaert S, Brown JB, Reichert SM, Harris SB. Real-World Incidence and Risk Indicator of Nonsevere Hypoglycemia in T1DM (InHypo-DM Study). Canadian Journal of Diabetes. 2019 Oct 1;43(7):S41-2.

Ratzki-Leewing A, Harris SB, Au NH, Webster-Bogaert S, Brown JB, Reichert SM, Ryan BL. Real-world Evidence That Impaired Awareness of Hypoglycemia Increases Severe Hypoglycemia Rates in T2DM (InHypo-DM Study). American Diabetes Association – 79th Scientific Sessions. Diabetes 2019 Jun;68(Suppl 1)

Ratzki-Leewing A, Harris SB, Au NH, Webster-Bogaert S, Brown JB, Reichert SM, Ryan BL. Real-world Risk Indicators of Impaired Awareness of Hypoglycemia in T2DM (InHypo-DM Study). American Diabetes Association – 79th Scientific Sessions. 2019.

Ratzki-Leewing A, Harris S, Mequanint S, Au N, Black JE, Reichert S, Brown JB, Ryan BL. Uncovering the Key Real-world Risk Indicator of Severe Hypoglycemia in T2DM (InHypo-DM Study). The Canadian Journal of Diabetes. 2018; 42(5): S52.

Au NH, Ratzki-Leewing A, Ryan BL, Mequanint S, Black JE, Reichert S, Brown JB, Harris S. Raising the Bar on Low Blood Sugar Management: Who’s At-Risk of Non-Severe Hypoglycemia? (InHypo-DM Study). The Canadian Journal of Diabetes. 2018; 42(5): S53.

Ratzki-Leewing A, Black JE, Mequanint S, Au NH, Ryan BL, Reichert S, Brown JB, Harris S. The “Unspoken” Truth: Suboptimal Reporting of Severe Hypoglycemia in Diabetes (InHypo-DM Study). The Canadian Journal of Diabetes. 2018; 42(5): S52-53.

Au NH, Ratzki-Leewing A, Ryan BL, Mequanint S, Black JE, Reichert S, Brown JB, Harris S. Common yet overlooked: non-severe hypoglycaemia and its risk indicators in type 2 diabetes (InHypo-DM Study). Diabetologia. 2018. 61(Suppl 1): S450.

Ratzki-Leewing A, Harris S, Mequanint S, Au N, Black JE, Reichert S, Brown JB, Ryan BL. Real-world risk indicators of severe hypoglycemia in T2D: Results of the InHypo-DM Study. Diabetes. 2018; 67(Suppl 1): 377-P.

Ratzki-Leewing A, Black JE, Mequanint S, Au NH, Ryan BL, Reichert S, Brown JB, Harris S. Severe hypoglycemia rates Are highest among those with sub-Optimal reporting behaviour: Results from the InHypo-DM Study. Diabetes. 2018; 67(Suppl 1): 399-P.

Au NH, Ratzki-Leewing A, Ryan BL, Mequanint S, Black JE, Reichert S, Brown JB, Harris S. Old but (unfortunately) not forgotten: The alarming use of outdated sulfonylureas (InHypo-DM Study). Diabetes. 2018; 67(Suppl 1): 127-LB.

Ratzki-Leewing A, Harris S, Ryan BL, Reichert S, Mequanint S, Webster-Bogaert S, and Brown JB. Hypoglycemia rates in type 2 diabetes mellitus differ by medication type (InHypo-DM Canada). The Canadian Journal of Diabetes. 2017; 41(5): S68-S69.

Reichert S, Ratzki-Leewing A, Ryan BL, Mequanint S, Webster-Bogaert S, Brown JB, Harris S. Experiences of hypoglycemia management from the significant others’ perspective: Insight from the InHypo-DM Study (Canada). The Canadian Journal of Diabetes. 2017; 41(5): S69.

Ratzki-Leewing A, Harris S, Ryan BL, Reichert S, Mequanint S, Webster-Bogaert S, Brown JB. Hypoglycemia rates in type 2 diabetes mellitus: Results of the population-based InHypo-DM Study (Canada). Diabetes. 2017; 66(Suppl 1): A107.

Reichert S, Ratzki-Leewing A, Ryan BL, Mequanint S, Webster-Bogaert S, Brown JB, Harris S. Hypoglycemia management through the eyes of the significant other: Highlights from the InHypo-DM Study (Canada). Diabetes. 2017; 66(Suppl 1):A106.

Harris S, Reichert S, Ryan B, Mequanint S, Webster-Bogaert S, Ratzki-Leewing A, Brown J. A population-based study on incidence and associated risk factors for hypoglycemia in Canada: The InHYPO-DM Study. The Canadian Journal of Diabetes. 2016; 40(5): S11-12.

Reichert S, Harris S, Ryan B, Mequanint S, Webster-Bogaert S, Ratzki-Leewing A, Brown J. A National Survey of physicians’ and allied health professionals’ practices and perspectives regarding hypoglycemia management: The InHYPO-DM Study. The Canadian Journal of Diabetes. 2016; 40(5): S58-S59.

Reichert S, Harris S, Ryan B, Mequanint S, Webster-Bogaert S, Ratzki-Leewing A, Brown JB. A population-based study on incidence and associated risk factors for hypoglycemia in Canada: the InHypo-DM study. Diabetologia. 2016; 59(Suppl 1): S394-395.

Ratzki-Leewing A, Harris SB, Ryan BL, Reichert S, Webster-Bogaert S. A survey of Canadians with diabetes: Insight into hypoglycemia management (The InHYPO-DM Study). Diabetes. 2016; 65(Suppl 1): A105.